The percentage of GPC1+ plasma exosomes in total plasma exosomes one day before surgery and 9-24 months after surgery was significantly higher in survived colon cancer patients with relapse than in the patients without relapse (Figure 5A). This evidence concerns the gene GPC1 and malignant colon neoplasm.